Biology Reference
In-Depth Information
107. Hutchinson PJ, O'Connell MT, Rothwell NJ, Hopkins SJ, Nortje J, Carpenter KLH, et al.
Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta,
and their endogenous inhibitor IL-1ra. J Neurotrauma 2007;24(10):1545-57.
108. Buttram SDW, Wisniewski SR, Jackson EK, Adelson PD, Feldman K, Bayir H, et al.
Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following
severe pediatric traumatic brain injury: effects of moderate hypothermia. J Neurotrauma
2007;24(11):1707-17.
109. Chiaretti A, Genovese O, Aloe L, Antonelli A, Piastra M, Polidori G, et al. Interleukin
1beta and interleukin 6 relationship with paediatric head trauma severity and outcome.
Childs Nerv Syst 2005;21(3):185-93. Discussion 194.
110. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, et al. Expression
of chemokine receptors by subsets of neurons in the central nervous system. J Immunol
1997;158(6):2882-90.
111. Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y. Astrocytes express functional
chemokine receptors. J Neuroimmunol 2000;111(1-2):109-21.
112. Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines
and chemokines. Neurochem Res 1998;23(3):329-40.
113. Wang J, Asensio VC, Campboll CL. Cytokines and chemokines as mediators of pro-
tection and injury in the central nervous system assessed in transgenic mice. Curr Top
Microbiol Immunol 2002;265:23-48.
114. Whalen MJ, Carlos TM, Kockanek PM, Wisniewski SR, Bell MJ, Clark RSB, et al.
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit
Care Med 2000;28:929-34.
115. Otto VI, Stahel PF, Rancan M, Kariya K, Shohami E, Yatsiv I, et al. Regulation of
chemokines and chemokine receptors after experimental closed head injury. Neuroreport
2001;12(9):2059-64.
116. Rhodes JKJ, Sharkey J, Andrews PJD. The temporal expression, cellular localisation,
and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the
rat. J Neurotrauma 2009;26:1-19.
117. Valles A, Grijpink-Ongering L, de Bree FM, Tuinstra T, Ronken E. Differential regula-
tion of the CXCR2 chemokine network in rat brain trauma: implications for neuroim-
mune interactions and neuronal survival. Neurobiol Dis 2006;22:312-22.
118. Glabinski AR, Balasingam V, Tani M, Kunkel SL, Strieter RM, Wee Yong V, et al.
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechan-
ical injury to the brain. J Immunol 1996;156:4363-68.
119. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells
directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003;23(21):7922-30.
120. Ehrenreich H, Bartels C, Sargin D, Stawicki S, Krampe H. Recombinant human eryth-
ropoietin in the treatment of human brain disease: focus on cognition. J Ren Nutr
2008;18(1):146-53.
121. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell
Death Differ 2004;11(Suppl. 1):S37-44.
122. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, et al. A
potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb
Blood Flow Metab 1999;19(6):643-51.
123. Liao ZB, Zhi XG, Shi QH, He ZH. Recombinant human erythropoietin adminis-
tration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol
2008;15(2):140-49.
